Clinical Study
Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients
Figure 3
Progression-free survival (PFS) in study and control group. The median PFS in study () and control group () was 16 and 10 months, respectively ().